AAAAAA

   
Results: 1-16 |
Results: 16
Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies
Authors: Pacheco-Tena, C de la Barrera, CA Lopez-Vidal, Y Vazquez-Mellado, J Richaud-Patin, Y Amieva, RI Llorente, L Martinez, A Zuniga, J Cifuentes-Alvarado, M Burgos-Vargas, R
Citation: C. Pacheco-tena et al., Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies, RHEUMATOLOG, 40(8), 2001, pp. 920-927
COX-2 inhibitors and gastrointestinal toxicity
Authors: Bombardier, C Laine, L Reicin, A Shapiro, D Burgos-Vargas, R Davis, B
Citation: C. Bombardier et al., COX-2 inhibitors and gastrointestinal toxicity, CAN MED A J, 164(8), 2001, pp. 1200-1200
The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ)
Authors: Duarte, C Ruperto, N Goycochea, M Maldonado, R Beristain, R De Inocencio, J Burgos-Vargas, R
Citation: C. Duarte et al., The Mexican version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ), CLIN EXP RH, 19(4), 2001, pp. S106-S110
Novel concepts of severity mechanisms in ankylosing spondylitis
Authors: Masi, AT King, JR Burgos-Vargas, R
Citation: At. Masi et al., Novel concepts of severity mechanisms in ankylosing spondylitis, J RHEUMATOL, 28(10), 2001, pp. 2151-2154
Relation between adverse events associated with allopurinol and renal function in patients with gout
Authors: Vazquez-Mellado, J Morales, EM Pacheco-Tena, C Burgos-Vargas, R
Citation: J. Vazquez-mellado et al., Relation between adverse events associated with allopurinol and renal function in patients with gout, ANN RHEUM D, 60(10), 2001, pp. 981-983
Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A
Authors: Duarte-Salazar, C Cazarin-Barrientos, J Goycochea-Robles, MV Collazo-Jaloma, J Burgos-Vargas, R
Citation: C. Duarte-salazar et al., Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A, RHEUMATOLOG, 39(10), 2000, pp. 1155-1157
Desensitization to allopurinol after allopurinol hypersensitivity syndromewith renal involvement in gout
Authors: Vazquez-Mellado, J Vazquez, SG Barrientos, JC Rios, VG Burgos-Vargas, R
Citation: J. Vazquez-mellado et al., Desensitization to allopurinol after allopurinol hypersensitivity syndromewith renal involvement in gout, JCR-J CLIN, 6(5), 2000, pp. 266-268
Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects
Authors: Cancino-Diaz, M Ayala-Narvaez, H Burgos-Vargas, R Reyes-Lopez, AS Tovar-Castillo, L Dominguez-Lopez, L Arreola, JG Jimenez-Zamudio, L Garcia-Latorre, E
Citation: M. Cancino-diaz et al., Recognition of B cells epitopes of the Klebsiella pneumoniae GroEL-like protein by HLA-B27 positive subjects, MICROB PATH, 28(4), 2000, pp. 211-220
Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ankylosing spondylitis
Authors: Dominguez-Lopez, ML Cancino-Diaz, ME Jimenez-Zamudio, L Granados-Arreola, J Burgos-Vargas, R Garcia-Latorre, E
Citation: Ml. Dominguez-lopez et al., Cellular immune response to Klebsiella pneumoniae antigens in patients with HLA-B27+ankylosing spondylitis, J RHEUMATOL, 27(6), 2000, pp. 1453-1460
Update on functional assessment tools
Authors: Duffy, CM Tucker, L Burgos-Vargas, R
Citation: Cm. Duffy et al., Update on functional assessment tools, J RHEUMATOL, 27, 2000, pp. 11-14
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen inpatients with rheumatoid arthritis.
Authors: Bombardier, C Laine, L Reicin, A Shapiro, D Burgos-Vargas, R Davis, B Day, R Ferraz, MB Hawkey, CJ Hochberg, MC Kvien, TK Schnitzer, TJ Weaver, A
Citation: C. Bombardier et al., Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen inpatients with rheumatoid arthritis., N ENG J MED, 343(21), 2000, pp. 1520-1528
Assessment of quality of life in children with rheumatic disease
Authors: Burgos-Vargas, R
Citation: R. Burgos-vargas, Assessment of quality of life in children with rheumatic disease, J RHEUMATOL, 26(7), 1999, pp. 1432-1435
A proposal for the classification of patients for clinical and experimental studies on reactive arthritis
Authors: Pacheco-Tena, C Burgos-Vargas, R Vazquez-Mellado, J Cazarin, J Perez-Diaz, JA
Citation: C. Pacheco-tena et al., A proposal for the classification of patients for clinical and experimental studies on reactive arthritis, J RHEUMATOL, 26(6), 1999, pp. 1338-1346
Intradermal tophi in gout: A case-control study
Authors: Vazquez-Mellado, J Cuan, A Magana, M Pineda, C Cazarin, J Pacheco-Tena, C Burgos-Vargas, R
Citation: J. Vazquez-mellado et al., Intradermal tophi in gout: A case-control study, J RHEUMATOL, 26(1), 1999, pp. 136-140
Open formulary proposal for a managed care program in Mexico.
Authors: Arredondo-Garcia, JL Bondani-Guasti, A Burgos-Vargas, R Castelazo-Morales, E de la Garza-Salazar, J Jerjes-Sanchez-Dias, C Kershenobich-Stalnikowitz, D Lifshitz-Guinzberg, A Zorrilla-Hernandez, E Viramontes-Madrid, JL
Citation: Jl. Arredondo-garcia et al., Open formulary proposal for a managed care program in Mexico., SALUD PUB M, 41(1), 1999, pp. 27-41
Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission - A twenty-four-week, single-blind, randomized study
Authors: Luis, M Pacheco-Tena, C Cazarin-Barrientos, J Lino-Perez, L Goycochea, MV Vazquez-Mellado, J Burgos-Vargas, R
Citation: M. Luis et al., Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission - A twenty-four-week, single-blind, randomized study, ARTH RHEUM, 42(10), 1999, pp. 2160-2165
Risultati: 1-16 |